“Improving prescription drug affordability for Medicare enrollees is the core of the Inflation Reduction Act, and the next ...

Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.

Drug pricing experts are not sure why rolling back drug pricing initiatives would be a day one priority for President Trump.

Republican lawmakers have proposed a raft of cost-cutting measures that could limit access to Medicaid and Medicare. Why It ...

For the ninth year, CMS has named McKesson a Qualified Clinical Data Registry approved to participate in the Merit-based ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...

The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage (MA) ...

Federal health agencies, including CMS, have halted almost all external communication as part of the presidential transition.

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

Federal health agencies, including the Centers for Medicare & Medicaid Services, have halted their communication efforts in ...